NOT KNOWN FACTS ABOUT WHERE TO PHENOBARBITAL

Contraindicated. Coadministration not suggested; potent cytochrome P450 enzyme inducers decrease systemic exposure to roflumilast and could reduce the therapeutic effectivenessB: Could be suitable. Either animal studies exhibit no chance but human reports not available or animal experiments showed insignificant challenges and human research perform